Declan Flynn

1.5k total citations · 1 hit paper
11 papers, 888 citations indexed

About

Declan Flynn is a scholar working on Molecular Biology, Physiology and Computational Theory and Mathematics. According to data from OpenAlex, Declan Flynn has authored 11 papers receiving a total of 888 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Physiology and 3 papers in Computational Theory and Mathematics. Recurrent topics in Declan Flynn's work include Computational Drug Discovery Methods (3 papers), Receptor Mechanisms and Signaling (3 papers) and Nitric Oxide and Endothelin Effects (2 papers). Declan Flynn is often cited by papers focused on Computational Drug Discovery Methods (3 papers), Receptor Mechanisms and Signaling (3 papers) and Nitric Oxide and Endothelin Effects (2 papers). Declan Flynn collaborates with scholars based in United States and Australia. Declan Flynn's co-authors include John E. Bleasdale, Jessica Ward, Boris A. Chrunyk, Brandon Pabst, Robert S. Garofalo, David Cunningham, Alison E. Varghese, Michelle Pacholec, Kay Ahn and Brian J. Stockman and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Journal of Medicinal Chemistry.

In The Last Decade

Declan Flynn

10 papers receiving 870 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

SRT1720, SRT2183, SRT1460, and Resveratrol Are Not Direct Activators of SIRT1

2010 723 citations Michelle Pacholec, John E. Bleasdale et al. Journal of Biological Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Declan Flynn United States	8	525	326	310	251	121	11	888
Brandon Pabst United States	7	525 1.0×	314 1.0×	412 1.3×	235 0.9×	121 1.0×	7	984
Michelle Pacholec United States	7	524 1.0×	301 0.9×	355 1.1×	230 0.9×	120 1.0×	7	870
Alison E. Varghese United States	3	524 1.0×	308 0.9×	280 0.9×	229 0.9×	120 1.0×	4	772
Stephen Marmor United States	6	416 0.8×	550 1.7×	429 1.4×	454 1.8×	48 0.4×	6	1.2k
Jessica A. Hall United States	19	114 0.2×	290 0.9×	495 1.6×	145 0.6×	31 0.3×	25	970
Irene Alfaras United States	16	235 0.4×	241 0.7×	300 1.0×	74 0.3×	17 0.1×	22	797
Nicola Giacchè Italy	13	163 0.3×	82 0.3×	283 0.9×	107 0.4×	90 0.7×	22	719
Yuyang Liu China	6	223 0.4×	107 0.3×	220 0.7×	119 0.5×	62 0.5×	11	568
Miriam Sindelar United States	15	135 0.3×	133 0.4×	724 2.3×	68 0.3×	64 0.5×	17	1.0k
Ian M. Robertson Canada	15	187 0.4×	120 0.4×	347 1.1×	45 0.2×	35 0.3×	29	808

Countries citing papers authored by Declan Flynn

Since Specialization

Citations

This map shows the geographic impact of Declan Flynn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Declan Flynn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Declan Flynn more than expected).

Fields of papers citing papers by Declan Flynn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Declan Flynn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Declan Flynn. The network helps show where Declan Flynn may publish in the future.

Co-authorship network of co-authors of Declan Flynn

This figure shows the co-authorship network connecting the top 25 collaborators of Declan Flynn. A scholar is included among the top collaborators of Declan Flynn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Declan Flynn. Declan Flynn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Sathish, Jean G., Declan Flynn, Stephen Jenkinson, et al.. (2022). Comprehensive Nonclinical Safety Assessment of Nirmatrelvir Supporting Timely Development of the SARS-COV-2 Antiviral Therapeutic, Paxlovid™. International Journal of Toxicology. 41(4). 276–290. 13 indexed citations

2.

Flynn, Declan, et al.. (2021). Efficacy of telemedicine on glycaemic control in patients with type 2 diabetes: A meta-analysis. World Journal of Diabetes. 12(2). 170–197. 42 indexed citations

3.

Li, Dingzhou, et al.. (2016). Statistical power analysis of cardiovascular safety pharmacology studies in conscious rats. Journal of Pharmacological and Toxicological Methods. 81. 128–135. 7 indexed citations

4.

Casimiro‐Garcia, Agustin, Christopher F. Bigge, Jing Chen, et al.. (2012). Design, synthesis, and evaluation of imidazo[4,5-c]pyridin-4-one derivatives with dual activity at angiotensin II type 1 receptor and peroxisome proliferator-activated receptor-γ. Bioorganic & Medicinal Chemistry Letters. 23(3). 767–772. 20 indexed citations

5.

Carpino, Philip A. & Declan Flynn. (2012). Review of Companies and Drug Classes in the 2007–2011 Antihypertensive Patent Literature. Pharmaceutical Patent Analyst. 1(1). 45–64. 1 indexed citations

6.

Casimiro‐Garcia, Agustin, Gary F. Filzen, Declan Flynn, et al.. (2011). Discovery of a Series of Imidazo[4,5-b]pyridines with Dual Activity at Angiotensin II Type 1 Receptor and Peroxisome Proliferator-Activated Receptor-γ. Journal of Medicinal Chemistry. 54(12). 4219–4233. 44 indexed citations

7.

Pacholec, Michelle, John E. Bleasdale, Boris A. Chrunyk, et al.. (2010). SRT1720, SRT2183, SRT1460, and Resveratrol Are Not Direct Activators of SIRT1. Journal of Biological Chemistry. 285(11). 8340–8351. 723 indexed citations breakdown →

8.

Gramza, Ann W., et al.. (2010). Activity of novel RET inhibitors against RET genotypes associated with medullary thyroid cancer.. Journal of Clinical Oncology. 28(15_suppl). 5559–5559. 1 indexed citations

9.

France, Charles P., Lisa R. Gerak, Declan Flynn, et al.. (1995). Behavioral effects and receptor binding affinities of fentanyl derivatives in rhesus monkeys.. Journal of Pharmacology and Experimental Therapeutics. 274(1). 17–28. 19 indexed citations

10.

Sargent, Carol A., et al.. (1995). Effect of Endothelin Antagonists With or Without BQ 788 on ET-1 Responses in Pithed Rats. Journal of Cardiovascular Pharmacology. 26. S216–218. 9 indexed citations

11.

Flynn, Declan, et al.. (1995). Sarafotoxin S6c Elicits a Non-ETA or Non-ETB-Mediated Pressor Response in the Pithed Rat. Journal of Cardiovascular Pharmacology. 26. S219–221. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact